Published • loading... • Updated
Verrica Pharmaceuticals (NASDAQ:VRCA) Upgraded at Wall Street Zen
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Verrica Pharmaceuticals (NASDAQ:VRCA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) from a strong sell rating to a sell rating in a report issued on Saturday morning,Wall Street Zen reports. Several other analysts also recently weighed in on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Verrica Pharmaceuticals in a […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
